COVID-19

The Ragon Institute of MGH, MIT and Harvard is a world-renowned leader in the study of immunology and infectious disease. In this time of crisis, we have turned our research focus solely to SARS-CoV-2, the coronavirus that causes the disease COVID-19. SARS-CoV2-19/COVID-19 represents the newest coronavirus to enter into the human population, causing over 1.5M infections and nearly 90,000 deaths to date. Working in collaboration with institutes, clinicians, and researchers across Massachusetts, we are committed to harnessing the immune system to end the global pandemic. 

Our swift, multi-faceted approach was greatly enabled by generous support from our donors, all of whom are committed to helping scientists combat this deadly, incredible disease. If you would like to donate to the Ragon Institute’s COVID-19 efforts, please follow this link. 

Our director, Bruce Walker, is a co-covenor of the Massachusetts Consortium for Pathogen Readiness. His expertise in infectious diseases and the immune system, as well as experience developing and supporting collaborative scientific communities, are a key to both the Ragon Institute’s and MassCPR’s strong response. 

We currently have a multi-pronged approach, encompassing six ongoing research projects from diagnostics to vaccine development; co-leadership and participation in the Massachusetts Consortium for Pathogen Readiness, a massive collaborative effort; certification of our BSL-3 laboratory for COVID-19 work; and a scientific advisory board dedicated to identifying and supporting projects with high potential for short term impact. This approach allows us to balance ensuring the safety of our workforce, who are working from home whenever possible, with the urgency of developing ways to combat COVID-19. 

For a description of our current research efforts, click here